Development of a novel formulation method to prepare liposomal Epacadostat-Reference-Cited by-同舟云学术

Development of a novel formulation method to prepare liposomal Epacadostat

Published:2021-10 Issue: Volume:165 Page:105954
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Tahaghoghi-Hajghorbani Sahar,Khoshkhabar Rahimeh,Rafiei Alireza,Ajami Abolghasem,Nikpoor Amin Reza,Jaafari Mahmoud Reza,Badiee Ali

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference45 articles.

1. Tryptophan catabolism and cancer immunotherapy targeting IDO mediated immune suppression;Amobi;Tumor Immune Microenviron. Cancer Progr. Cancer Ther.,2017

2. Doxil®—the first FDA-approved nano-drug: lessons learned;Barenholz;J. Control. Release,2012

3. Phosphorus assay in column chromatography;Bartlett;J. Biol. Chem.,1959

4. Cancer immunotherapy: a promising dawn in cancer research;Bondhopadhyay;Am. J. Blood Res.,2020

5. An autocrine cytokine/JAK/STAT-signaling induces kynurenine synthesis in multidrug resistant human cancer cells;Campia;PLoS ONE,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sphingomyelin-derived nanovesicles for the delivery of the IDO1 inhibitor epacadostat enhance metastatic and post-surgical melanoma immunotherapy;Nature Communications;2023-11-09

2. Targeting the tumor microenvironment by liposomal Epacadostat in combination with liposomal gp100 vaccine;Scientific Reports;2023-04-10

3. Advancements in nanoparticle-based treatment approaches for skin cancer therapy;Molecular Cancer;2023-01-12

4. Role of Physicochemical Factors on the Efficacy and Safety of Lipid-Based Nanosystems as Potential Drug Carriers;Nano;2021-12-10